Demeunynck M - Search Results

1

3,4-Dihydro-1H-[1,3]oxazino[4,5-c]acridines as a new family of cytotoxic drugs.

Ouberai M, Asche C, Carrez D, Croisy A, Dumy P, Demeunynck M. Ouberai M, et al. Among authors: demeunynck m. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4641-3. doi: 10.1016/j.bmcl.2006.05.101. Epub 2006 Jun 13. Bioorg Med Chem Lett. 2006. PMID: 16777412

2

Search for DNA repair inhibitors: selective binding of nucleic bases-acridine conjugates to a DNA duplex containing an abasic site.

Berthet N, Constant JF, Demeunynck M, Michon P, Lhomme J. Berthet N, et al. Among authors: demeunynck m. J Med Chem. 1997 Oct 10;40(21):3346-52. doi: 10.1021/jm970225t. J Med Chem. 1997. PMID: 9341909

3

Introduction of a nitroxide group on position 2 of 9-phenoxyacridine: easy access to spin labelled DNA-binding conjugates.

Belmont P, Chapelle C, Demeunynck M, Michon J, Michon P, Lhomme J. Belmont P, et al. Among authors: demeunynck m. Bioorg Med Chem Lett. 1998 Mar 17;8(6):669-74. doi: 10.1016/s0960-894x(98)00089-4. Bioorg Med Chem Lett. 1998. PMID: 9871580

4

Synthesis of an imidazo[1,2-e]purine-acridine heterodimer for targeting abasic sites in DNA.

Belmont P, Alarcon K, Demeunynck M, Lhomme J. Belmont P, et al. Among authors: demeunynck m. Bioorg Med Chem Lett. 1999 Jan 18;9(2):233-6. doi: 10.1016/s0960-894x(98)00703-3. Bioorg Med Chem Lett. 1999. PMID: 10021935

5

Abasic site recognition in DNA as a new strategy to potentiate the action of anticancer alkylating drugs?

Belmont P, Jourdan M, Demeunynck M, Constant JF, Garcia J, Lhomme J, Carez D, Croisy A. Belmont P, et al. Among authors: demeunynck m. J Med Chem. 1999 Dec 16;42(25):5153-9. doi: 10.1021/jm9901428. J Med Chem. 1999. PMID: 10602700

6

Synthesis and study of a new adenine-acridine tandem, inhibitor of exonuclease III.

Belmont P, Demeunynck M, Constant JF, Lhomme J. Belmont P, et al. Among authors: demeunynck m. Bioorg Med Chem Lett. 2000 Feb 7;10(3):293-5. doi: 10.1016/s0960-894x(99)00681-2. Bioorg Med Chem Lett. 2000. PMID: 10698457

7

The abasic site as a target for generation of locally multiply damaged sites.

Martelli A, Berthet N, Constant JF, Demeunynck M, Lhomme J. Martelli A, et al. Among authors: demeunynck m. Bioorg Med Chem Lett. 2000 Apr 17;10(8):763-6. doi: 10.1016/s0960-894x(00)00081-0. Bioorg Med Chem Lett. 2000. PMID: 10782681

8

Potentiation of BCNU cytotoxicity by molecules targeting abasic lesions in DNA.

Alarcon K, Demeunynck M, Lhomme J, Carrez D, Croisy A. Alarcon K, et al. Among authors: demeunynck m. Bioorg Med Chem. 2001 Jul;9(7):1901-10. doi: 10.1016/s0968-0896(01)00097-9. Bioorg Med Chem. 2001. PMID: 11425593

9

Diaminopurine-acridine heterodimers for specific recognition of abasic site containing DNA. Influence on the biological activity of the position of the linker on the purine ring.

Alarcon K, Demeunynck M, Lhomme J, Carrez D, Croisy A. Alarcon K, et al. Among authors: demeunynck m. Bioorg Med Chem Lett. 2001 Jul 23;11(14):1855-8. doi: 10.1016/s0960-894x(01)00310-9. Bioorg Med Chem Lett. 2001. PMID: 11459646

10

4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.

Charmantray F, Demeunynck M, Carrez D, Croisy A, Lansiaux A, Bailly C, Colson P. Charmantray F, et al. Among authors: demeunynck m. J Med Chem. 2003 Mar 13;46(6):967-77. doi: 10.1021/jm020389w. J Med Chem. 2003. PMID: 12620073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters